Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Etoposide

2

X.g Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)

2
Last update : 09/08/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

[Etoposide desensitization. A case report].
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2010;57;33-6 2010
Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide.
British journal of cancer 2002 Jan 07;86;12-3 2002 Jan 07
Hypersensitivity reactions to etoposide. A report of three cases and review of the literature.
American journal of clinical oncology 1994 Oct;17;387-9 1994 Oct
Two cases of suspected immunologic-based hypersensitivity reactions to etoposide therapy.
The Annals of pharmacotherapy 1992 Oct;26;1227-30 1992 Oct
Hypersensitivity reactions induced by etoposide.
Cancer treatment reports 1984;68;959-61 1984

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies